Veterinary Precision Medicine Market Size, Share & Trends Analysis Report By Type, By Animal, By Therapeutic Area, By Customer, By Region, And Segment Forecasts, 2026

The global veterinary precision medicine market size was estimated at USD 558.9 million in 2025 and is projected to reach USD 1,509.5 million by 2033, growing at a CAGR of 13.5% from 2026 to 2033. The market is growing due to factors such as rising companion animal cancer prevalence, pet humanization boosting treatment investment, AI/ML advancing bioinformatics capabilities, and comparative oncology attracting institutional investment.

The global veterinary precision medicine industry encompasses genomic profiling, molecular diagnostics, precision therapy guidance, and bioinformatics services delivered across companion and production animals, spanning oncology, infectious diseases, immunology, and other therapeutic areas. Commercial service adoption is currently primarily in canine oncology, with expanding applications in feline and other species. The integration of artificial intelligence and machine learning into bioinformatics platforms has significantly elevated the clinical utility of veterinary precision medicine services. Computational models are now capable of converting complex multi-omics and live-cell datasets into individualized, actionable treatment guidance; a capability that was not achievable through conventional genomic analysis alone.

For instance, ImpriMed's platform represents the most commercially validated application of this shift. Its Drug Response Predictions service uses AI models trained on extensive, clinically proven data sources to generate personalized treatment predictions for canine cancer patients, analyzing the efficacy of up to 13 commonly prescribed blood cancer drugs on patients' living cells, with results delivered within 6 to 7 days. Dogs with relapsed B-cell lymphoma treated under ImpriMed's AI-guided predictions recorded a median survival time of 160 to 187 days, as published in Frontiers in Oncology, and 95% of surveyed veterinary oncologists reported satisfaction with the service. To date, ImpriMed's tests have been applied to over 3,700 canine and feline patients over five years, with over 10,000 individual samples analyzed. Furthermore, AI applications are expanding beyond drug response prediction into imaging diagnostics, where machine learning algorithms are being trained to detect tumor-associated abnormalities in radiographic and histopathological data. This broadening of AI utility across the diagnostic and bioinformatics service stack positions the technology as a structural market driver rather than a niche capability.

The translational value of companion animal cancer models is accelerating institutional and commercial investment in veterinary precision medicine infrastructure. Naturally occurring cancers in companion animals share key biological and molecular characteristics with human malignancies, with cross-species insights already informing advances such as limb-sparing surgical techniques derived from canine osteosarcoma research and improved understanding of hormonal influences in human breast cancer through feline mammary tumor studies. A study published in February 2026, conducted across institutions including the Wellcome Sanger Institute, the University of Guelph, and the University of Bern, mapped the oncogenome of the domestic cat across nearly 500 tumor samples sourced from five countries. The study was funded by the EveryCat Health Foundation, CVS Group, Wellcome, the Natural Sciences and Engineering Research Council of Canada, and the Swiss National Science Foundation. This scale of multi-national, multi-funder investment signals a structural shift in how comparative oncology is being prioritized at the institutional level.

In addition, expanding comparative oncology research through broad, multicenter veterinary clinical trials is identified as essential for bridging gaps between preclinical findings and clinical practice, with collaborative networks spanning academic institutions, veterinary practices, industry partners, and regulatory bodies forming translational research frameworks. This institutional convergence is directly expanding the demand and funding base for veterinary precision medicine services.

Global Veterinary Precision Medicine Market Report Segmentation

This report forecasts revenue growth at the global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the veterinary precision medicine market report based on type, animal, therapeutic area, customer, and region:

Type Outlook (Revenue, USD Million, 2021 - 2033)
Genomic Profiling & Sequencing
Diagnostic & Pathology
Precision Therapy & Treatment
Bioinformatics & Data Analytics
Animal Outlook (Revenue, USD Million, 2021 - 2033)
Dogs
Cats
Other Animals
Therapeutic Area Outlook (Revenue, USD Million, 2021 - 2033)
Oncology
Infectious Diseases
Immunology & Autoimmune Disorders
Musculoskeletal Disorders
Other Therapeutic Areas
Customer Outlook (Revenue, USD Million, 2021 - 2033)
Veterinary Hospitals & Clinics
Veterinary Academic & Research Institutions
Veterinary Diagnostic Laboratories
Other Customers
Regional Outlook (Revenue, USD Million, 2021 - 2033)
North America
- U.S.
- Canada
- Mexico
Europe
- UK
- Germany
- France
- Italy
- Spain
- Denmark
- Sweden
- Norway
Asia Pacific
- China
- Japan
- India
- Australia
- South Korea
- Thailand
Latin America
- Brazil
- Argentina
Middle East & Africa
- South Africa
- Saudi Arabia
- UAE
- Kuwait
- Oman
- Qatar

Product Code: GVR-4-68040-900-6

Chapter 1. Methodology and Scope

1.1. Market Segmentation and Scope
1.2. Segment Definitions
- 1.2.1. Type
- 1.2.2. Animal
- 1.2.3. Therapeutic Area
- 1.2.4. Customers
1.3. Research Methodology
1.4. Information Procurement
- 1.4.1. Purchased Database
- 1.4.2. GVR's Internal Database
- 1.4.3. Secondary Sources
- 1.4.4. Primary Research
1.5. Information/Data Analysis
- 1.5.1. Data Analysis Models
1.6. Market Formulation & Validation
1.7. Model Details
- 1.7.1. Model 1: Commodity Flow Analysis
- 1.7.2. Model 2: Bottom-Up Analysis
- 1.7.3. Model 3: Volume-Pricing Analysis
1.8. List of Secondary Sources
1.9. List Of Abbreviations
1.10. Objectives

Chapter 2. Executive Summary

2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights

Chapter 3. Market Variable Trends & Scope

3.1. Market Lineage Outlook
- 3.1.1. Parent Market Outlook
- 3.1.2. Ancillary/Related Market Outlook
3.2. Market Dynamics
- 3.2.1. Market Driver Analysis
  - 3.2.1.1. Rising Companion Animal Cancer Prevalence
  - 3.2.1.2. Pet Humanization Boosting Treatment Investment
  - 3.2.1.3. AI/ML Advancing Bioinformatics Capabilities
  - 3.2.1.4. Comparative Oncology Attracting Institutional Investment
- 3.2.2. Market Restraint Analysis
  - 3.2.2.1. High Costs Limiting Clinical Adoption
  - 3.2.2.2. Limited Validated Multi-Species Assays
- 3.2.3. Market Opportunity Analysis
- 3.2.4. Market Challenge Analysis
3.3. Pricing Model Analysis
3.4. User Perspective Analysis
3.5. Case Study Analysis
3.6. Market Analysis Tools
- 3.6.1. Porter's Five Forces Analysis
- 3.6.2. PESTEL by SWOT Analysis

Chapter 4. Veterinary Precision Medicine Market: By Type Estimates & Trend Analysis

4.1. Veterinary Precision Medicine Market, By Type: Segment Dashboard
4.2. Veterinary Precision Medicine Market, By Type: Movement Analysis
4.3. Veterinary Precision Medicine Market Estimates & Forecasts, by Type, 2021 to 2033 (USD Million)
4.4. Genomic Profiling & Sequencing
- 4.4.1. Genomic Profiling & Sequencing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
4.5. Diagnostic & Pathology
- 4.5.1. Diagnostic & Pathology Market Estimates and Forecasts, 2021 - 2033 (USD Million)
4.6. Precision Therapy & Treatment
- 4.6.1. Precision Therapy & Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
4.7. Bioinformatics & Data Analytics
- 4.7.1. Bioinformatics & Data Analytics Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 5. Veterinary Precision Medicine Market: By Animal Estimates & Trend Analysis

5.1. Veterinary Precision Medicine Market, By Animal: Segment Dashboard
5.2. Veterinary Precision Medicine Market, By Animal Movement Analysis
5.3. Veterinary Precision Medicine Market Estimates & Forecasts, by Animal, 2021 to 2033 (USD Million)
5.4. Dogs
- 5.4.1. Dogs Market Estimates and Forecasts, 2021 - 2033 (USD Million)
5.5. Cats
- 5.5.1. Cats Market Estimates and Forecasts, 2021 - 2033 (USD Million)
5.6. Other Animals
- 5.6.1. Other Animals Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 6. Veterinary Precision Medicine Market: By Therapeutic Area Estimates & Trend Analysis

6.1. Veterinary Precision Medicine Market, By Therapeutic Area: Segment Dashboard
6.2. Veterinary Precision Medicine Market, By Therapeutic Area Movement Analysis
6.3. Veterinary Precision Medicine Market Estimates & Forecasts, by Therapeutic Area, 2021 to 2033 (USD Million)
6.4. Oncology
- 6.4.1. Oncology Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.5. Infectious Diseases
- 6.5.1. Infectious Diseases Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.6. Immunology & Autoimmune Disorders
- 6.6.1. Immunology & Autoimmune Disorders Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.7. Musculoskeletal Disorders
- 6.7.1. Musculoskeletal Disorders Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.8. Other Therapeutic Areas
- 6.8.1. Other Therapeutic Areas Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 7. Veterinary Precision Medicine Market: By Customer Estimates & Trend Analysis

7.1. Veterinary Precision Medicine Market, By Customer: Segment Dashboard
7.2. Veterinary Precision Medicine Market, By Customer Movement Analysis
7.3. Veterinary Precision Medicine Market Estimates & Forecasts, by Customer, 2021 to 2033 (USD Million)
7.4. Veterinary Hospitals & Clinics
- 7.4.1. Veterinary Hospitals & Clinics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
7.5. Veterinary Academic & Research Institutions
- 7.5.1. Veterinary Academic & Research Institutions Market Estimates and Forecasts, 2021 - 2033 (USD Million)
7.6. Veterinary Diagnostic Laboratories
- 7.6.1. Veterinary Diagnostic Laboratories Market Estimates and Forecasts, 2021 - 2033 (USD Million)
7.7. Other Customers
- 7.7.1. Other Customers Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 8. Veterinary Precision Medicine Market: By Regional Estimates & Trend Analysis

8.1. Region Market Dashboard
8.2. Region Market Share Analysis, 2025 & 2033
8.3. North America
- 8.3.1. North America Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 8.3.2. U.S
  - 8.3.2.1. Key Country Dynamics
  - 8.3.2.2. Competitive Scenario
  - 8.3.2.3. Regulatory Framework
  - 8.3.2.4. U.S. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 8.3.3. Canada
  - 8.3.3.1. Key Country Dynamics
  - 8.3.3.2. Competitive Scenario
  - 8.3.3.3. Regulatory Framework
  - 8.3.3.4. Canada Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 8.3.4. Mexico
  - 8.3.4.1. Key Country Dynamics
  - 8.3.4.2. Competitive Scenario
  - 8.3.4.3. Regulatory Framework
  - 8.3.4.4. Mexico Market Estimates and Forecasts, 2021 - 2033 (USD Million)
8.4. Europe
- 8.4.1. Europe Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 8.4.2. UK
  - 8.4.2.1. Key Country Dynamics
  - 8.4.2.2. Competitive Scenario
  - 8.4.2.3. Regulatory Framework
  - 8.4.2.4. UK Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 8.4.3. Germany
  - 8.4.3.1. Key Country Dynamics
  - 8.4.3.2. Competitive Scenario
  - 8.4.3.3. Regulatory Framework
  - 8.4.3.4. Germany Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 8.4.4. France
  - 8.4.4.1. Key Country Dynamics
  - 8.4.4.2. Competitive Scenario
  - 8.4.4.3. Regulatory Framework
  - 8.4.4.4. France Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 8.4.5. Italy
  - 8.4.5.1. Key Country Dynamics
  - 8.4.5.2. Competitive Scenario
  - 8.4.5.3. Regulatory Framework
  - 8.4.5.4. Italy Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 8.4.6. Spain
  - 8.4.6.1. Key Country Dynamics
  - 8.4.6.2. Competitive Scenario
  - 8.4.6.3. Regulatory Framework
  - 8.4.6.4. Spain Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 8.4.7. Denmark
  - 8.4.7.1. Key Country Dynamics
  - 8.4.7.2. Competitive Scenario
  - 8.4.7.3. Regulatory Framework
  - 8.4.7.4. Denmark Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 8.4.8. Sweden
  - 8.4.8.1. Key Country Dynamics
  - 8.4.8.2. Competitive Scenario
  - 8.4.8.3. Regulatory Framework
  - 8.4.8.4. Sweden Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 8.4.9. Norway
  - 8.4.9.1. Key Country Dynamics
  - 8.4.9.2. Competitive Scenario
  - 8.4.9.3. Regulatory Framework
  - 8.4.9.4. Norway Market Estimates and Forecasts, 2021 - 2033 (USD Million)
8.5. Asia Pacific
- 8.5.1. Asia Pacific Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 8.5.2. Japan
  - 8.5.2.1. Key Country Dynamics
  - 8.5.2.2. Competitive Scenario
  - 8.5.2.3. Regulatory Framework
  - 8.5.2.4. Japan Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 8.5.3. China
  - 8.5.3.1. Key Country Dynamics
  - 8.5.3.2. Competitive Scenario
  - 8.5.3.3. Regulatory Framework
  - 8.5.3.4. China Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 8.5.4. India
  - 8.5.4.1. Key Country Dynamics
  - 8.5.4.2. Competitive Scenario
  - 8.5.4.3. Regulatory Framework
  - 8.5.4.4. India Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 8.5.5. Australia
  - 8.5.5.1. Key Country Dynamics
  - 8.5.5.2. Competitive Scenario
  - 8.5.5.3. Regulatory Framework
  - 8.5.5.4. Australia Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 8.5.6. Thailand
  - 8.5.6.1. Key Country Dynamics
  - 8.5.6.2. Competitive Scenario
  - 8.5.6.3. Regulatory Framework
  - 8.5.6.4. Thailand Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 8.5.7. South Korea
  - 8.5.7.1. Key Country Dynamics
  - 8.5.7.2. Competitive Scenario
  - 8.5.7.3. Regulatory Framework
  - 8.5.7.4. South Korea Market Estimates and Forecasts, 2021 - 2033 (USD Million)
8.6. Latin America
- 8.6.1. Latin America Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 8.6.2. Brazil
  - 8.6.2.1. Key Country Dynamics
  - 8.6.2.2. Competitive Scenario
  - 8.6.2.3. Regulatory Framework
  - 8.6.2.4. Brazil Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 8.6.3. Argentina
  - 8.6.3.1. Key Country Dynamics
  - 8.6.3.2. Competitive Scenario
  - 8.6.3.3. Regulatory Framework
  - 8.6.3.4. Argentina Market Estimates and Forecasts, 2021 - 2033 (USD Million)
8.7. MEA
- 8.7.1. MEA Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 8.7.2. South Africa
  - 8.7.2.1. Key Country Dynamics
  - 8.7.2.2. Competitive Scenario
  - 8.7.2.3. Regulatory Framework
  - 8.7.2.4. South Africa Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 8.7.3. UAE
  - 8.7.3.1. Key Country Dynamics
  - 8.7.3.2. Competitive Scenario
  - 8.7.3.3. Regulatory Framework
  - 8.7.3.4. UAE Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 8.7.4. Saudi Arabia
  - 8.7.4.1. Key Country Dynamics
  - 8.7.4.2. Competitive Scenario
  - 8.7.4.3. Regulatory Framework
  - 8.7.4.4. Saudi Arabia Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 8.7.5. Kuwait
  - 8.7.5.1. Key Country Dynamics
  - 8.7.5.2. Competitive Scenario
  - 8.7.5.3. Regulatory Framework
  - 8.7.5.4. Kuwait Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 8.7.6. Qatar
  - 8.7.6.1. Key Country Dynamics
  - 8.7.6.2. Competitive Scenario
  - 8.7.6.3. Regulatory Framework
  - 8.7.6.4. Qatar Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 8.7.7. Oman
  - 8.7.7.1. Key Country Dynamics
  - 8.7.7.2. Competitive Scenario
  - 8.7.7.3. Regulatory Framework
  - 8.7.7.4. Oman Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 9. Competitive Landscape

9.1. Market Participant Categorization
- 9.1.1. Market Leaders
- 9.1.2. Emerging Players
9.2. Market Share/Assessment Analysis, 2025 (Heat Map Analysis)
9.3. Company Profiles
- 9.3.1. Zoetis
  - 9.3.1.1. Participant's Overview
  - 9.3.1.2. Financial Performance
  - 9.3.1.3. Product/Service Benchmarking
  - 9.3.1.4. Strategic Initiatives
- 9.3.2. Idexx Laboratories
  - 9.3.2.1. Participant's Overview
  - 9.3.2.2. Financial Performance
  - 9.3.2.3. Product/Service Benchmarking
  - 9.3.2.4. Strategic Initiatives
- 9.3.3. ImpriMed
  - 9.3.3.1. Participant's Overview
  - 9.3.3.2. Financial Performance
  - 9.3.3.3. Product/Service Benchmarking
  - 9.3.3.4. Strategic Initiatives
- 9.3.4. FidoCure (One Health Company)
  - 9.3.4.1. Participant's Overview
  - 9.3.4.2. Financial Performance
  - 9.3.4.3. Product/Service Benchmarking
  - 9.3.4.4. Strategic Initiatives
- 9.3.5. Anivive Lifesciences (Vidium Animal Health)
  - 9.3.5.1. Participant's Overview
  - 9.3.5.2. Financial Performance
  - 9.3.5.3. Product/Service Benchmarking
  - 9.3.5.4. Strategic Initiatives
- 9.3.6. VetOmics Animal Health
  - 9.3.6.1. Participant's Overview
  - 9.3.6.2. Financial Performance
  - 9.3.6.3. Product/Service Benchmarking
  - 9.3.6.4. Strategic Initiatives
- 9.3.7. LEAH Labs
  - 9.3.7.1. Participant's Overview
  - 9.3.7.2. Financial Performance
  - 9.3.7.3. Product/Service Benchmarking
  - 9.3.7.4. Strategic Initiatives
- 9.3.8. Elias Animal Health
  - 9.3.8.1. Participant's Overview
  - 9.3.8.2. Financial Performance
  - 9.3.8.3. Product/Service Benchmarking
  - 9.3.8.4. Strategic Initiatives
- 9.3.9. testblu diagnostics GmbH
  - 9.3.9.1. Participant's Overview
  - 9.3.9.2. Financial Performance
  - 9.3.9.3. Product/Service Benchmarking
  - 9.3.9.4. Strategic Initiatives
- 9.3.10. PetDx
  - 9.3.10.1. Participant's Overview
  - 9.3.10.2. Financial Performance
  - 9.3.10.3. Product/Service Benchmarking
  - 9.3.10.4. Strategic Initiatives
- 9.3.11. Torigen, Inc
  - 9.3.11.1. Participant's Overview
  - 9.3.11.2. Financial Performance
  - 9.3.11.3. Product/Service Benchmarking
  - 9.3.11.4. Strategic Initiatives
- 9.3.12. Oxford BioDynamics
  - 9.3.12.1. Participant's Overview
  - 9.3.12.2. Financial Performance
  - 9.3.12.3. Product/Service Benchmarking
  - 9.3.12.4. Strategic Initiatives

Product Code: GVR-4-68040-900-6

List of Tables

Table 1 List of Secondary Sources
Table 2 List of Abbreviations
Table 3 Global Veterinary Precision Medicine Market, By Type, 2021 - 2033 (USD Million)
Table 4 Global Veterinary Precision Medicine Market, By Animal, 2021 - 2033 (USD Million)
Table 5 Global Veterinary Precision Medicine Market, By Therapeutic Area, 2021 - 2033 (USD Million)
Table 6 Global Veterinary Precision Medicine Market, By Customer, 2021 - 2033 (USD Million)
Table 7 North America Veterinary Precision Medicine Market, By Type, 2021 - 2033 (USD Million)
Table 8 North America Veterinary Precision Medicine Market, By Animal, 2021 - 2033 (USD Million)
Table 9 North America Veterinary Precision Medicine Market, By Therapeutic Area, 2021 - 2033 (USD Million)
Table 10 North America Veterinary Precision Medicine Market, By Customer, 2021 - 2033 (USD Million)
Table 11 U.S. Veterinary Precision Medicine Market, By Type, 2021 - 2033 (USD Million)
Table 12 U.S. Veterinary Precision Medicine Market, By Animal, 2021 - 2033 (USD Million)
Table 13 U.S. Veterinary Precision Medicine Market, By Therapeutic Area, 2021 - 2033 (USD Million)
Table 14 U.S. Veterinary Precision Medicine Market, By Customer, 2021 - 2033 (USD Million)
Table 15 Canada Veterinary Precision Medicine Market, By Type, 2021 - 2033 (USD Million)
Table 16 Canada Veterinary Precision Medicine Market, By Animal, 2021 - 2033 (USD Million)
Table 17 Canada Veterinary Precision Medicine Market, By Therapeutic Area, 2021 - 2033 (USD Million)
Table 18 Canada Veterinary Precision Medicine Market, By Customer, 2021 - 2033 (USD Million)
Table 19 Mexico Veterinary Precision Medicine Market, By Type, 2021 - 2033 (USD Million)
Table 20 Mexico Veterinary Precision Medicine Market, By Animal, 2021 - 2033 (USD Million)
Table 21 Mexico Veterinary Precision Medicine Market, By Therapeutic Area, 2021 - 2033 (USD Million)
Table 22 Mexico Veterinary Precision Medicine Market, By Customer, 2021 - 2033 (USD Million)
Table 23 Europe Veterinary Precision Medicine Market, By Type, 2021 - 2033 (USD Million)
Table 24 Europe Veterinary Precision Medicine Market, By Animal, 2021 - 2033 (USD Million)
Table 25 Europe Veterinary Precision Medicine Market, By Therapeutic Area, 2021 - 2033 (USD Million)
Table 26 Europe Veterinary Precision Medicine Market, By Customer, 2021 - 2033 (USD Million)
Table 27 UK Veterinary Precision Medicine Market, By Type, 2021 - 2033 (USD Million)
Table 28 UK Veterinary Precision Medicine Market, By Animal, 2021 - 2033 (USD Million)
Table 29 UK Veterinary Precision Medicine Market, By Therapeutic Area, 2021 - 2033 (USD Million)
Table 30 UK Veterinary Precision Medicine Market, By Customer, 2021 - 2033 (USD Million)
Table 31 Germany Veterinary Precision Medicine Market, By Type, 2021 - 2033 (USD Million)
Table 32 Germany Veterinary Precision Medicine Market, By Animal, 2021 - 2033 (USD Million)
Table 33 Germany Veterinary Precision Medicine Market, By Therapeutic Area, 2021 - 2033 (USD Million)
Table 34 Germany Veterinary Precision Medicine Market, By Customer, 2021 - 2033 (USD Million)
Table 35 France Veterinary Precision Medicine Market, By Type, 2021 - 2033 (USD Million)
Table 36 France Veterinary Precision Medicine Market, By Animal, 2021 - 2033 (USD Million)
Table 37 France Veterinary Precision Medicine Market, By Therapeutic Area, 2021 - 2033 (USD Million)
Table 38 France Veterinary Precision Medicine Market, By Customer, 2021 - 2033 (USD Million)
Table 39 Italy Veterinary Precision Medicine Market, By Type, 2021 - 2033 (USD Million)
Table 40 Italy Veterinary Precision Medicine Market, By Animal, 2021 - 2033 (USD Million)
Table 41 Italy Veterinary Precision Medicine Market, By Therapeutic Area, 2021 - 2033 (USD Million)
Table 42 Italy Veterinary Precision Medicine Market, By Customer, 2021 - 2033 (USD Million)
Table 43 Spain Veterinary Precision Medicine Market, By Type, 2021 - 2033 (USD Million)
Table 44 Spain Veterinary Precision Medicine Market, By Animal, 2021 - 2033 (USD Million)
Table 45 Spain Veterinary Precision Medicine Market, By Therapeutic Area, 2021 - 2033 (USD Million)
Table 46 Spain Veterinary Precision Medicine Market, By Customer, 2021 - 2033 (USD Million)
Table 47 Denmark Veterinary Precision Medicine Market, By Type, 2021 - 2033 (USD Million)
Table 48 Denmark Veterinary Precision Medicine Market, By Animal, 2021 - 2033 (USD Million)
Table 49 Denmark Veterinary Precision Medicine Market, By Therapeutic Area, 2021 - 2033 (USD Million)
Table 50 Denmark Veterinary Precision Medicine Market, By Customer, 2021 - 2033 (USD Million)
Table 51 Sweden Veterinary Precision Medicine Market, By Type, 2021 - 2033 (USD Million)
Table 52 Sweden Veterinary Precision Medicine Market, By Animal, 2021 - 2033 (USD Million)
Table 53 Sweden Veterinary Precision Medicine Market, By Therapeutic Area, 2021 - 2033 (USD Million)
Table 54 Sweden Veterinary Precision Medicine Market, By Customer, 2021 - 2033 (USD Million)
Table 55 Norway Veterinary Precision Medicine Market, By Type, 2021 - 2033 (USD Million)
Table 56 Norway Veterinary Precision Medicine Market, By Animal, 2021 - 2033 (USD Million)
Table 57 Norway Veterinary Precision Medicine Market, By Therapeutic Area, 2021 - 2033 (USD Million)
Table 58 Norway Veterinary Precision Medicine Market, By Customer, 2021 - 2033 (USD Million)
Table 59 Asia Pacific Veterinary Precision Medicine Market, By Type, 2021 - 2033 (USD Million)
Table 60 Asia Pacific Veterinary Precision Medicine Market, By Animal, 2021 - 2033 (USD Million)
Table 61 Asia Pacific Veterinary Precision Medicine Market, By Therapeutic Area, 2021 - 2033 (USD Million)
Table 62 Asia Pacific Veterinary Precision Medicine Market, By Customer, 2021 - 2033 (USD Million)
Table 63 Japan Veterinary Precision Medicine Market, By Type, 2021 - 2033 (USD Million)
Table 64 Japan Veterinary Precision Medicine Market, By Animal, 2021 - 2033 (USD Million)
Table 65 Japan Veterinary Precision Medicine Market, By Therapeutic Area, 2021 - 2033 (USD Million)
Table 66 Japan Veterinary Precision Medicine Market, By Customer, 2021 - 2033 (USD Million)
Table 67 China Veterinary Precision Medicine Market, By Type, 2021 - 2033 (USD Million)
Table 68 China Veterinary Precision Medicine Market, By Animal, 2021 - 2033 (USD Million)
Table 69 China Veterinary Precision Medicine Market, By Therapeutic Area, 2021 - 2033 (USD Million)
Table 70 China Veterinary Precision Medicine Market, By Customer, 2021 - 2033 (USD Million)
Table 71 India Veterinary Precision Medicine Market, By Type, 2021 - 2033 (USD Million)
Table 72 India Veterinary Precision Medicine Market, By Animal, 2021 - 2033 (USD Million)
Table 73 India Veterinary Precision Medicine Market, By Therapeutic Area, 2021 - 2033 (USD Million)
Table 74 India Veterinary Precision Medicine Market, By Customer, 2021 - 2033 (USD Million)
Table 75 Australia Veterinary Precision Medicine Market, By Type, 2021 - 2033 (USD Million)
Table 76 Australia Veterinary Precision Medicine Market, By Animal, 2021 - 2033 (USD Million)
Table 77 Australia Veterinary Precision Medicine Market, By Therapeutic Area, 2021 - 2033 (USD Million)
Table 78 Australia Veterinary Precision Medicine Market, By Customer, 2021 - 2033 (USD Million)
Table 79 South Korea Veterinary Precision Medicine Market, By Type, 2021 - 2033 (USD Million)
Table 80 South Korea Veterinary Precision Medicine Market, By Animal, 2021 - 2033 (USD Million)
Table 81 South Korea Veterinary Precision Medicine Market, By Therapeutic Area, 2021 - 2033 (USD Million)
Table 82 South Korea Veterinary Precision Medicine Market, By Customer, 2021 - 2033 (USD Million)
Table 83 Thailand Veterinary Precision Medicine Market, By Type, 2021 - 2033 (USD Million)
Table 84 Thailand Veterinary Precision Medicine Market, By Animal, 2021 - 2033 (USD Million)
Table 85 Thailand Veterinary Precision Medicine Market, By Therapeutic Area, 2021 - 2033 (USD Million)
Table 86 Thailand Veterinary Precision Medicine Market, By Customer, 2021 - 2033 (USD Million)
Table 87 Latin America Veterinary Precision Medicine Market, By Type, 2021 - 2033 (USD Million)
Table 88 Latin America Veterinary Precision Medicine Market, By Animal, 2021 - 2033 (USD Million)
Table 89 Latin America Veterinary Precision Medicine Market, By Therapeutic Area, 2021 - 2033 (USD Million)
Table 90 Latin America Veterinary Precision Medicine Market, By Customer, 2021 - 2033 (USD Million)
Table 91 Brazil Veterinary Precision Medicine Market, By Type, 2021 - 2033 (USD Million)
Table 92 Brazil Veterinary Precision Medicine Market, By Animal, 2021 - 2033 (USD Million)
Table 93 Brazil Veterinary Precision Medicine Market, By Therapeutic Area, 2021 - 2033 (USD Million)
Table 94 Brazil Veterinary Precision Medicine Market, By Customer, 2021 - 2033 (USD Million)
Table 95 Argentina Veterinary Precision Medicine Market, By Type, 2021 - 2033 (USD Million)
Table 96 Argentina Veterinary Precision Medicine Market, By Animal, 2021 - 2033 (USD Million)
Table 97 Argentina Veterinary Precision Medicine Market, By Therapeutic Area, 2021 - 2033 (USD Million)
Table 98 Argentina Veterinary Precision Medicine Market, By Customer, 2021 - 2033 (USD Million)
Table 99 Middle East & Africa (MEA) Veterinary Precision Medicine Market, By Type, 2021 - 2033 (USD Million)
Table 100 Middle East & Africa (MEA) Veterinary Precision Medicine Market, By Animal, 2021 - 2033 (USD Million)
Table 101 Middle East & Africa (MEA) Veterinary Precision Medicine Market, By Therapeutic Area, 2021 - 2033 (USD Million)
Table 102 Middle East & Africa (MEA) Veterinary Precision Medicine Market, By Customer, 2021 - 2033 (USD Million)
Table 103 South Africa Veterinary Precision Medicine Market, By Type, 2021 - 2033 (USD Million)
Table 104 South Africa Veterinary Precision Medicine Market, By Animal, 2021 - 2033 (USD Million)
Table 105 South Africa Veterinary Precision Medicine Market, By Therapeutic Area, 2021 - 2033 (USD Million)
Table 106 South Africa Veterinary Precision Medicine Market, By Customer, 2021 - 2033 (USD Million)
Table 107 Saudi Arabia Veterinary Precision Medicine Market, By Type, 2021 - 2033 (USD Million)
Table 108 Saudi Arabia Veterinary Precision Medicine Market, By Animal, 2021 - 2033 (USD Million)
Table 109 Saudi Arabia Veterinary Precision Medicine Market, By Therapeutic Area, 2021 - 2033 (USD Million)
Table 110 Saudi Arabia Veterinary Precision Medicine Market, By Customer, 2021 - 2033 (USD Million)
Table 111 UAE Veterinary Precision Medicine Market, By Type, 2021 - 2033 (USD Million)
Table 112 UAE Veterinary Precision Medicine Market, By Animal, 2021 - 2033 (USD Million)
Table 113 UAE Veterinary Precision Medicine Market, By Therapeutic Area, 2021 - 2033 (USD Million)
Table 114 UAE Veterinary Precision Medicine Market, By Customer, 2021 - 2033 (USD Million)
Table 115 Kuwait Veterinary Precision Medicine Market, By Type, 2021 - 2033 (USD Million)
Table 116 Kuwait Veterinary Precision Medicine Market, By Animal, 2021 - 2033 (USD Million)
Table 117 Kuwait Veterinary Precision Medicine Market, By Therapeutic Area, 2021 - 2033 (USD Million)
Table 118 Kuwait Veterinary Precision Medicine Market, By Customer, 2021 - 2033 (USD Million)
Table 119 Oman Veterinary Precision Medicine Market, By Type, 2021 - 2033 (USD Million)
Table 120 Oman Veterinary Precision Medicine Market, By Animal, 2021 - 2033 (USD Million)
Table 121 Oman Veterinary Precision Medicine Market, By Therapeutic Area, 2021 - 2033 (USD Million)
Table 122 Oman Veterinary Precision Medicine Market, By Customer, 2021 - 2033 (USD Million)
Table 123 Qatar Veterinary Precision Medicine Market, By Type, 2021 - 2033 (USD Million)
Table 124 Qatar Veterinary Precision Medicine Market, By Animal, 2021 - 2033 (USD Million)
Table 125 Qatar Veterinary Precision Medicine Market, By Therapeutic Area, 2021 - 2033 (USD Million)
Table 126 Qatar Veterinary Precision Medicine Market, By Customer, 2021 - 2033 (USD Million)

List of Figures

Fig. 1 Market research process
Fig. 2 Information Procurement
Fig. 3 Primary Research Pattern
Fig. 4 Market Research Approaches
Fig. 5 Value Chain-Based Sizing & Forecasting
Fig. 6 Market Formulation & Validation
Fig. 7 Veterinary Precision Medicine Market, Market Segmentation
Fig. 8 Market Driver Relevance Analysis (Current & Future Impact)
Fig. 9 Market Restraint Relevance Analysis (Current & Future Impact)
Fig. 10 Market Challenge Relevance Analysis (Current & Future Impact)
Fig. 11 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
Fig. 12 Porter's Five Forces Analysis
Fig. 13 Regional Marketplace: Key Takeaways
Fig. 14 Global Veterinary Precision Medicine Market, for Type, 2021 - 2033 (USD Million)
Fig. 15 Global Veterinary Precision Medicine Market, for Genomic Profiling & Sequencing, 2021 - 2033 (USD Million)
Fig. 16 Global Veterinary Precision Medicine Market, for Diagnostic & Pathology, 2021 - 2033 (USD Million)
Fig. 17 Global Veterinary Precision Medicine Market, for Precision Therapy & Treatment, 2021 - 2033 (USD Million)
Fig. 18 Global Veterinary Precision Medicine Market, for Bioinformatics & Data Analytics, 2021 - 2033 (USD Million)
Fig. 19 Global Veterinary Precision Medicine Market, for Animal, 2021 - 2033 (USD Million)
Fig. 20 Global Veterinary Precision Medicine Market, for Dogs, 2021 - 2033 (USD Million)
Fig. 21 Global Veterinary Precision Medicine Market, for Cats, 2021 - 2033 (USD Million)
Fig. 22 Global Veterinary Precision Medicine Market, for Other Animals, 2021 - 2033 (USD Million)
Fig. 23 Global Veterinary Precision Medicine Market, for Therapeutic Area, 2021 - 2033 (USD Million)
Fig. 24 Global Veterinary Precision Medicine Market, for Oncology, 2021 - 2033 (USD Million)
Fig. 25 Global Veterinary Precision Medicine Market, for Infectious Diseases, 2021 - 2033 (USD Million)
Fig. 26 Global Veterinary Precision Medicine Market, for Immunology & Autoimmune Disorders, 2021 - 2033 (USD Million)
Fig. 27 Global Veterinary Precision Medicine Market, for Musculoskeletal Disorders, 2021 - 2033 (USD Million)
Fig. 28 Global Veterinary Precision Medicine Market, for Other Therapeutic Areas, 2021 - 2033 (USD Million)
Fig. 29 Global Veterinary Precision Medicine Market, for Customers, 2021 - 2033 (USD Million)
Fig. 30 Global Veterinary Precision Medicine Market, for Veterinary Hospitals & Clinics, 2021 - 2033 (USD Million)
Fig. 31 Global Veterinary Precision Medicine Market, for Veterinary Academic & Research Institutions, 2021 - 2033 (USD Million)
Fig. 32 Global Veterinary Precision Medicine Market, for Veterinary Diagnostic Laboratories, 2021 - 2033 (USD Million)
Fig. 33 Global Veterinary Precision Medicine Market, for Other Customers, 2021 - 2033 (USD Million)
Fig. 34 Regional Outlook, 2025 & 2033
Fig. 35 North America Veterinary Precision Medicine Market, 2021 - 2033 (USD Million)
Fig. 36 Key Country Dynamics
Fig. 37 U.S. Veterinary Precision Medicine Market, 2021 - 2033 (USD Million)
Fig. 38 Key Country Dynamics
Fig. 39 Canada Veterinary Precision Medicine Market, 2021 - 2033 (USD Million)
Fig. 40 Key Country Dynamics
Fig. 41 Mexico Veterinary Precision Medicine Market, 2021 - 2033 (USD Million)
Fig. 42 Europe Veterinary Precision Medicine Market, 2021 - 2033 (USD Million)
Fig. 43 Key Country Dynamics
Fig. 44 UK Veterinary Precision Medicine Market, 2021 - 2033 (USD Million)
Fig. 45 Key Country Dynamics
Fig. 46 Germany Veterinary Precision Medicine Market, 2021 - 2033 (USD Million)
Fig. 47 Key Country Dynamics
Fig. 48 France Veterinary Precision Medicine Market, 2021 - 2033 (USD Million)
Fig. 49 Key Country Dynamics
Fig. 50 Italy Veterinary Precision Medicine Market, 2021 - 2033 (USD Million)
Fig. 51 Key Country Dynamics
Fig. 52 Spain Veterinary Precision Medicine Market, 2021 - 2033 (USD Million)
Fig. 53 Key Country Dynamics
Fig. 54 Denmark Veterinary Precision Medicine Market, 2021 - 2033 (USD Million)
Fig. 55 Key Country Dynamics
Fig. 56 Sweden Veterinary Precision Medicine Market, 2021 - 2033 (USD Million)
Fig. 57 Key Country Dynamics
Fig. 58 Norway Veterinary Precision Medicine Market, 2021 - 2033 (USD Million)
Fig. 59 Asia Pacific Veterinary Precision Medicine Market, 2021 - 2033 (USD Million)
Fig. 60 Key Country Dynamics
Fig. 61 Japan Veterinary Precision Medicine Market, 2021 - 2033 (USD Million)
Fig. 62 Key Country Dynamics
Fig. 63 China Veterinary Precision Medicine Market, 2021 - 2033 (USD Million)
Fig. 64 Key Country Dynamics
Fig. 65 India Veterinary Precision Medicine Market, 2021 - 2033 (USD Million)
Fig. 66 Key Country Dynamics
Fig. 67 Australia Veterinary Precision Medicine Market, 2021 - 2033 (USD Million)
Fig. 68 Key Country Dynamics
Fig. 69 South Korea Veterinary Precision Medicine Market, 2021 - 2033 (USD Million)
Fig. 70 Key Country Dynamics
Fig. 71 Thailand Veterinary Precision Medicine Market, 2021 - 2033 (USD Million)
Fig. 72 North America
Fig. 73 Key Country Dynamics
Fig. 74 Brazil Veterinary Precision Medicine Market, 2021 - 2033 (USD Million)
Fig. 75 Key Country Dynamics
Fig. 76 Argentina Veterinary Precision Medicine Market, 2021 - 2033 (USD Million)
Fig. 77 Middle East & Africa (MEA)Veterinary Precision Medicine Market, 2021 - 2033 (USD Million)
Fig. 78 Key Country Dynamics
Fig. 79 South Africa Veterinary Precision Medicine Market, 2021 - 2033 (USD Million)
Fig. 80 Key Country Dynamics
Fig. 81 Saudi Arabia Veterinary Precision Medicine Market, 2021 - 2033 (USD Million)
Fig. 82 Key Country Dynamics
Fig. 83 UAE Veterinary Precision Medicine Market, 2021 - 2033 (USD Million)
Fig. 84 Key Country Dynamics
Fig. 85 Kuwait Veterinary Precision Medicine Market, 2021 - 2033 (USD Million)
Fig. 86 Key Country Dynamics
Fig. 87 Oman Veterinary Precision Medicine Market, 2021 - 2033 (USD Million)
Fig. 88 Key Country Dynamics
Fig. 89 Qatar Veterinary Precision Medicine Market, 2021 - 2033 (USD Million)

Veterinary Precision Medicine Market Size, Share & Trends Analysis Report By Type, By Animal, By Therapeutic Area, By Customer, By Region, And Segment Forecasts, 2026 - 2033

Description

Table of Contents

List of Tables

Veterinary Precision Medicine Market Summary

Table of Contents

Chapter 1. Methodology and Scope

Chapter 2. Executive Summary

Chapter 3. Market Variable Trends & Scope

Chapter 4. Veterinary Precision Medicine Market: By Type Estimates & Trend Analysis

Chapter 5. Veterinary Precision Medicine Market: By Animal Estimates & Trend Analysis

Chapter 6. Veterinary Precision Medicine Market: By Therapeutic Area Estimates & Trend Analysis

Chapter 7. Veterinary Precision Medicine Market: By Customer Estimates & Trend Analysis

Chapter 8. Veterinary Precision Medicine Market: By Regional Estimates & Trend Analysis

Chapter 9. Competitive Landscape

List of Tables

List of Figures